SC seeks Centre’s reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19
Seeking CBI probe, Advocate Sharma had filed the PIL alleging that these two medicines have been wrongly manufactured and sold.
Full Article
SC seeks Centre’s reply on plea alleging no approval for Remdesivir, Favipiravir to treat COVID-19
Hindu
0 shares
1 views
You might like
Related news coverage
Supreme Court takes into account WHO report on Remdesivir, seeks Centre's response
The Supreme Court on Thursday took into account a World Health Organisation report, indicating that Remdesivir, hydroxychloroquine,..
Mid-Day